| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 250,250 | Sold Some | -17,500 | -6.53 % | $5,505,500 | $5,868,363 | $362,863 | 6.59 % | $-25,375 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2009-08-03 | 2009-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 267,750 | Added More | 25,000 | 10.29 % | $4,425,908 | $6,278,738 | $1,852,830 | 41.86 % | $173,000 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2009-05-04 | 2009-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 242,750 | Added More | 55,000 | 29.29 % | $2,682,388 | $5,692,488 | $3,010,100 | 112.21 % | $682,000 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2009-02-13 | 2008-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 187,750 | Added More | 56,800 | 43.37 % | $2,472,668 | $4,402,738 | $1,930,070 | 78.05 % | $583,904 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2008-11-06 | 2008-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 130,950 | Sold Some | -135,000 | -50.76 % | $1,292,477 | $3,070,778 | $1,778,301 | 137.58 % | $-1,833,300 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2008-08-14 | 2008-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 265,950 | Added More | 54,000 | 25.47 % | $3,989,250 | $6,236,528 | $2,247,278 | 56.33 % | $456,300 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2008-05-14 | 2008-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 211,950 | Added More | 150,900 | 247.17 % | $3,670,974 | $4,970,228 | $1,299,254 | 35.39 % | $925,017 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2008-02-14 | 2007-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 61,050 | Added More | 1,000 | 1.66 % | $1,205,738 | $1,431,623 | $225,885 | 18.73 % | $3,700 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2007-11-14 | 2007-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 60,050 | Added More | 1,000 | 1.69 % | $1,070,692 | $1,408,173 | $337,481 | 31.51 % | $5,620 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2007-08-10 | 2007-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 59,050 | Added More | 14,870 | 33.65 % | $1,290,243 | $1,384,723 | $94,480 | 7.32 % | $23,792 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2007-05-15 | 2007-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 44,180 | No Change | 0 | 0 % | $1,165,468 | $1,036,021 | $-129,447 | -11.10 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2007-02-14 | 2006-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 44,180 | No Change | 0 | 0 % | $1,111,569 | $1,036,021 | $-75,548 | -6.79 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2006-11-14 | 2006-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 44,180 | No Change | 0 | 0 % | $817,330 | $1,036,021 | $218,691 | 26.75 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2006-08-14 | 2006-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 44,180 | No Change | 0 | 0 % | $736,922 | $1,036,021 | $299,099 | 40.58 % | $0 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2006-05-15 | 2006-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 44,180 | Sold Some | -10,820 | -19.67 % | $989,190 | $1,036,021 | $46,831 | 4.73 % | $-11,469 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2006-02-14 | 2005-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 55,000 | Sold Some | -35 | -0.06 % | $1,822,700 | $1,289,750 | $-532,950 | -29.23 % | $339 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2005-11-10 | 2005-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 55,035 | Sold Some | -35,815 | -39.42 % | $1,411,097 | $1,290,571 | $-120,527 | -8.54 % | $78,435 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2005-08-08 | 2005-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 90,850 | Sold Some | -1,330 | -1.44 % | $2,153,145 | $2,130,433 | $-22,713 | -1.05 % | $333 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2005-05-05 | 2005-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 92,180 | Added More | 49,080 | 113.87 % | $2,700,874 | $2,161,621 | $-539,253 | -19.96 % | $-287,118 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2005-02-10 | 2004-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 43,100 | Added More | 22,900 | 113.36 % | $1,611,940 | $1,010,695 | $-601,245 | -37.29 % | $-319,455 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
| 2004-11-17 | 2004-09-30 | 13F-HR/A | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 20,200 | New Holding | 20,200 | 100 % | $766,590 | $473,690 | $-292,900 | -38.20 % | $-292,900 | | | | | | History of Schwab Charles Investment Management Inc Ownership Of Par Pharmaceutical Cos Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |